Sanofi opened its new 900,000-sq.-ft. campus at Cambridge Crossing in Cambridge, MA, one of the company’s largest U.S. sites. The campus is designed to enhance collaboration between R&D, Medical, and the Specialty Care business unit, among others, to help accelerate the development of transformative treatments.
 
Bill Sibold, Executive Vice President, Head of Global Specialty Care, Sanofi, said, “Cambridge has been our home for many years. Opening our new facility in Cambridge Crossing is allowing us to bring together our employees across Massachusetts under one roof – which is an important step in facilitating the kind of collaboration needed to fulfill our purpose of chasing the miracles of science to improve people’s lives.”
 
Sanofi at Cambridge Crossing consists of two buildings, both U.S. Green Building Council LEED Gold Certified, located at 450 Water Street and 350 Water Street. The campus incorporates state–of–the–art environmental features, including automated light dimming, CO2 sensors, and advanced heating/cooling systems. WaterSense fixtures will harvest rainwater and create up to 60 percent water efficiency, from the EPA baseline.
 
John Reed, M.D., Ph.D., Executive Vice President, Global Head of Research and Development, Sanofi, said, “We have built an unparalleled facility for our R&D community in Cambridge with a focus on ultra-modern laboratories in close proximity to our scientific and commercial colleagues. Located in the heart of an innovation ecosystem, our new site will serve as an open space to connect our experts with key partners, including top academic research institutions and hospitals, with the goal of urgently meeting patient needs through the tireless advance of science.”